Loading provider…
Loading provider…
Neurological Surgery Physician in Omaha, NE
NPI: 1083693287Primary Practice Location
THE NEBRASKA MEDICAL CENTER
4350 Dewey Ave, Omaha, NE
Primary Employer
Neurology Consultants of Nebraska PC
nebraskaneurology.com
HQ Phone
Get M.D. Pamela's Phone Numberphone_androidMobile
Get M.D. Pamela's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNE State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 253 | 505 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 39 | 44 |
| 3 | J0585Injection, onabotulinumtoxina, 1 unit | 34 | 23,300 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 18 | 18 |
| 5 | 64615Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 17 | 47 |
Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson's disease.
Authors: Heinrichs-Graham, Elizabeth, Wilson, Tony W, Santamaria, Pamela M, Heithoff, Sheila K, Torres-Russotto, Diego, Hutter-Saunders, Jessica A L, Estes, Katherine A, Meza, Jane L, Mosley, R L, Gendelman, Howard E
Journal: Cereb Cortex
Publication Date: 2013-05-03
CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.
Authors: David Standaert, John Bertoni, Diego Torres-Russotto, Daniel Murman
Journal: J Neuroimmune Pharmacol
Publication Date: 2012-10-11
Authors: Wiesman, Alex I, Heinrichs-Graham, Elizabeth, McDermott, Timothy J, Santamaria, Pamela M, Gendelman, Howard E, Wilson, Tony W
Journal: Hum Brain Mapp
Publication Date: 2016-05-06
Lead Sponsor: ACADIA Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Pimavanserin 20 mg, DRUG: Pimavanserin 34 mg